BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 3157164)

  • 1. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
    Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
    Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bromocriptine for prolactin-secreting macroadenomas of the pituitary].
    Landman L; Spindel A; Tal Y; Bar-Meir A; Sharf M; Dickstein G
    Harefuah; 1987 Oct; 113(7-8):156-9. PubMed ID: 3428740
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of tumours of the sellar region. Evaluation of treatment with bromocriptine retard.
    Lundberg PO; Bergström K; Thuomas KA; Muhr C; Enoksson P
    Acta Radiol Suppl; 1986; 369():310-3. PubMed ID: 2980483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bromocriptine treatment of prolactinomas and primary hyperprolactinemia (author's transl)].
    Fossati P; Grenier JL; Stevenard C; Fermon C; Christiaens JL; Linquette M
    Ann Med Interne (Paris); 1982; 133(1):45-7. PubMed ID: 7065588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
    Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
    Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
    [No Abstract]   [Full Text] [Related]  

  • 10. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
    Tindall GT; Kovacs K; Horvath E; Thorner MO
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
    Hubbard JL; Scheithauer BW; Abboud CF; Laws ER
    J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of postoperative bromocriptine treatment for prolactin-secreting pituitary adenomas].
    Sato O; Niwa J; Inoue Y; Akagawa S; Kobayashi K
    No Shinkei Geka; 1983 Jan; 11(1):51-60. PubMed ID: 6682184
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
    N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA; Chang RJ
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolactin-secreting pituitary adenomas in children and adolescents. Study of a series of 8 cases].
    Barrio R; Roger M; Chaussain JL; Job JC
    Arch Fr Pediatr; 1979; 36(8):785-93. PubMed ID: 539871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regression with purely medical treatment of pituitary prolactin adenomas].
    Bricaire H
    Ann Med Interne (Paris); 1982; 133(1):58. PubMed ID: 7065591
    [No Abstract]   [Full Text] [Related]  

  • 18. Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.
    Nissim M; Ambrosi B; Bernasconi V; Giannattasio G; Giovanelli MA; Bassetti M; Vaccari U; Moriondo P; Spada A; Travaglini P; Faglia G
    J Endocrinol Invest; 1982; 5(6):409-15. PubMed ID: 7169515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
    Scherrer H; Turpin G; De Gennes JL; Schaison-Cusin M; Heshmati HM; Thibierge M; Metzger J
    Ann Med Interne (Paris); 1985; 136(6):459-66. PubMed ID: 4083636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
    Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.